These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 15694201

  • 21. Demyelination in peroxisomal diseases.
    Powers JM.
    J Neurol Sci; 2005 Feb 15; 228(2):206-7. PubMed ID: 15694208
    [No Abstract] [Full Text] [Related]

  • 22. [Development and regeneration of oligodendrocytes: therapeutic perspectives in demyelinating diseases].
    Dubois-Dalcq M.
    Bull Mem Acad R Med Belg; 2005 Feb 15; 160(10-12):407-15; discussion 415-6. PubMed ID: 16768245
    [Abstract] [Full Text] [Related]

  • 23. Central nervous system myelin: structure, synthesis and assembly.
    Aggarwal S, Yurlova L, Simons M.
    Trends Cell Biol; 2011 Oct 15; 21(10):585-93. PubMed ID: 21763137
    [Abstract] [Full Text] [Related]

  • 24. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
    Jacobs EC.
    J Neurol Sci; 2005 Feb 15; 228(2):195-7. PubMed ID: 15694204
    [No Abstract] [Full Text] [Related]

  • 25. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system.
    Bosio A, Büssow H, Adam J, Stoffel W.
    Cell Tissue Res; 1998 May 15; 292(2):199-210. PubMed ID: 9560463
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Toxic nervous pathology: biochemistry of myelin and demyelinizing conditions].
    Baumann N.
    Eur J Toxicol; 1972 May 15; 5(1):7-11. PubMed ID: 4647427
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Insulating axons via NF-kappaB.
    Mattson MP.
    Nat Neurosci; 2003 Feb 15; 6(2):105-6. PubMed ID: 12555100
    [No Abstract] [Full Text] [Related]

  • 36. Myosin II has distinct functions in PNS and CNS myelin sheath formation.
    Wang H, Tewari A, Einheber S, Salzer JL, Melendez-Vasquez CV.
    J Cell Biol; 2008 Sep 22; 182(6):1171-84. PubMed ID: 18794332
    [Abstract] [Full Text] [Related]

  • 37. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
    Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR.
    Brain; 2002 Mar 22; 125(Pt 3):551-61. PubMed ID: 11872612
    [Abstract] [Full Text] [Related]

  • 38. High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the light- and electron-microscopic level.
    Savaskan NE, Weinmann O, Heimrich B, Eyupoglu IY.
    Cell Tissue Res; 2009 Aug 22; 337(2):213-21. PubMed ID: 19513756
    [Abstract] [Full Text] [Related]

  • 39. Remyelination of the central nervous system: a valuable contribution from the periphery.
    Zujovic V, Bachelin C, Baron-Van Evercooren A.
    Neuroscientist; 2007 Aug 22; 13(4):383-91. PubMed ID: 17644768
    [Abstract] [Full Text] [Related]

  • 40. Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia.
    Rotshenker S, Reichert F, Gitik M, Haklai R, Elad-Sfadia G, Kloog Y.
    Glia; 2008 Nov 15; 56(15):1607-13. PubMed ID: 18615637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.